The Influence of Kynurenine Metabolites on Neurodegenerative Pathologies
International Journal of Molecular Sciences · 10.01.2024 · 25 (2) · 853
DOI: 10.3390/ijms25020853 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 10.01.2024. Verfasst von Suhrud Pathak und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Drug Discovery and Development, Harrison College of Pharmacy, Auburn University, Auburn, AL 36849, USA. Hauptthemen laut MEDLINE: Kynurenine, Cognition Disorders. Die Arbeit wurde bisher 95-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
As the kynurenine pathway’s links to inflammation, the immune system, and neurological disorders became more apparent, it attracted more and more attention. It is the main pathway through which the liver breaks down Tryptophan and the initial step in the creation of nicotinamide adenine dinucleotide (NAD+) in mammals. Immune system activation and the buildup of potentially neurotoxic substances can result from the dysregulation or overactivation of this pathway. Therefore, it is not shocking that kynurenines have been linked to neurological conditions (Depression, Parkinson’s, Alzheimer’s, Huntington’s Disease, Schizophrenia, and cognitive deficits) in relation to inflammation. Nevertheless, preclinical research has demonstrated that kynurenines are essential components of the behavioral analogs of depression and schizophrenia-like cognitive deficits in addition to mediators associated with neurological pathologies due to their neuromodulatory qualities. Neurodegenerative diseases have been extensively associated with neuroactive metabolites of the kynurenine pathway (KP) of tryptophan breakdown. In addition to being a necessary amino acid for protein synthesis, Tryptophan is also transformed into the important neurotransmitters tryptamine and serotonin in higher eukaryotes. In this article, a summary of the KP, its function in neurodegeneration, and the approaches being used currently to target the route therapeutically are discussed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Drug Discovery and Development, Harrison College of Pharmacy, Auburn University, Auburn, AL 36849, USA.
- Blast-Induced Neurotrauma Branch, Center for Military Psychiatry and Neuroscience, Walter Reed Army Institute of Research, Silver Spring, MD 20910, USA.
- Department of Pharmacy Practice, Harrison College of Pharmacy, Auburn University, Auburn, AL 36849, USA.
ORCID-Profile: Manoj Govindarajulu, Courtney S Watts Alexander, Muralikrishnan Dhanasekaran
Zitieren
APA
Pathak, S., Nadar, R., Kim, S., Liu, K., Govindarajulu, M., Cook, P., Watts Alexander, C. S., Dhanasekaran, M., & Moore, T. (2024). The Influence of Kynurenine Metabolites on Neurodegenerative Pathologies. International Journal of Molecular Sciences, 25(2), 853. https://doi.org/10.3390/ijms25020853
Vancouver
Pathak S, Nadar R, Kim S, Liu K, Govindarajulu M, Cook P, et al. The Influence of Kynurenine Metabolites on Neurodegenerative Pathologies. International Journal of Molecular Sciences. 2024;25(2):853. doi:10.3390/ijms25020853
BibTeX
@article{Pathak2024,
author = {Pathak, Suhrud and Nadar, Rishi and Kim, Shannon and Liu, Keyi and Govindarajulu, Manoj and Cook, Preston and Watts Alexander, Courtney S and Dhanasekaran, Muralikrishnan and Moore, Timothy},
title = {The Influence of Kynurenine Metabolites on Neurodegenerative Pathologies},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {2},
pages = {853},
doi = {10.3390/ijms25020853}
}
EUVIMED